Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).

26 . 7 . 4

Circles or ellipses with lines (except 26.7.3)Cercles ou ellipses avec lignes (excepté 26.7.3)

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 5

Thin linesLignes fines

26 . 11 . 7

Vertical lines or bandsLignes ou bandes verticales

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 9

Oblique lines or bandsLignes ou bandes obliques

26 . 11 . 10

Straight lines or bandsLignes ou bandes droites

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

26 . 11 . 11

Broken lines or bands (except a 26.11.13)Lignes ou bandes brisées (excepté a 26.11.13)

Trademark usage description

providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluat Read More

Classification Information

Class [042]
Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services.

Classification kind code

Class [044]
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services.

Classification kind code

Mark Details

Serial Number

2165245

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 14 on 11^th Oct 2023	Default Notice Sent
Submitted for opposition 22 on 16^th Mar 2023	Search Recorded
Submitted for opposition 20 on 16^th Mar 2023	Examiner's First Report
Submitted for opposition 223 on 16^th Mar 2023	Total Provisional Refusal
Submitted for opposition 256 on 12^th Dec 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 10^th Feb 2022	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 09^th Feb 2022	Created
Submitted for opposition 31 on 09^th Feb 2022	Formalized
Submitted for opposition 30 on 21^st Jul 2021	Filed
Submitted for opposition 228 on 21^st Jul 2021	International Registration